Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection

Time to AIDS in HIV-2 infection is approximately twice as long compared to in HIV-1 infection. Despite reduced viremia, HIV-2-infected individuals display signs of chronic immune activation. In HIV-1-infected individuals, B-cell hyperactivation is driven by continuous antigen exposure. However, the contribution of viremia to B-cell perturbations in HIV-2-infected individuals remains largely unexplored. Here, we used polychromatic flow cytometry, consensus hierarchical clustering and pseudotime trajectory inference to characterize B-cells in HIV-1- or HIV-2-infected and in HIV seronegative individuals. We observed increased frequencies of clusters containing hyperactivated T-bethighCD95highCD27int and proliferating T-bet+CD95highCD27+CD71+ memory B-cells in viremic HIV-1 (p < 0.001 and p < 0.001, respectively), viremic HIV-2 (p < 0.001 and p = 0.014, respectively) and in treatment-naïve aviremic HIV-2 (p = 0.004 and p = 0.020, respectively)-infected individuals, compared to seronegative individuals. In contrast, these expansions were not observed in successfully treated HIV-1-infected individuals. Finally, pseudotime trajectory inference showed that T-bet-expressing hyperactivated and proliferating memory B-cell populations were located at the terminal end of two trajectories, in both HIV-1 and HIV-2 infections. As the treatment-naïve aviremic HIV-2-infected individuals, but not the successfully ART-treated HIV-1-infected individuals, showed B-cell perturbations, our data suggest that aviremic HIV-2-infected individuals would also benefit from antiretroviral treatment.

[1]  F. Månsson,et al.  Interferon Alpha-Inducible Protein 27 Expression Is Linked to Disease Severity in Chronic Infection of Both HIV-1 and HIV-2 , 2022, Frontiers in Virology.

[2]  S. Calza,et al.  Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated Infection , 2022, Mediterranean journal of hematology and infectious diseases.

[3]  F. Månsson,et al.  Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals , 2021, Frontiers in Immunology.

[4]  Y. Saeys,et al.  PeacoQC: Peak‐based selection of high quality cytometry data , 2021, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[5]  Y. Saeys,et al.  Analyzing high-dimensional cytometry data using FlowSOM , 2021, Nature Protocols.

[6]  Harinder Singh,et al.  T-bet+CD27+CD21– B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants , 2021, JCI insight.

[7]  L. Hanna,et al.  Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4+ T Cells in the Pathogenesis of HIV-2 Infection and Disease Progression , 2021, Frontiers in Immunology.

[8]  Jinyan Huang,et al.  CytoTree: an R/Bioconductor package for analysis and visualization of flow and mass cytometry data , 2021, BMC Bioinformatics.

[9]  James L. Melville.  The Uniform Manifold Approximation and Projection (UMAP) Method for Dimensionality Reduction [R package uwot version 0.1.10] , 2020 .

[10]  Lisa E. Wagar,et al.  An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity , 2020, Immunity.

[11]  Erik B van den Akker,et al.  A Comprehensive Workflow for Applying Single-Cell Clustering and Pseudotime Analysis to Flow Cytometry Data , 2020, The Journal of Immunology.

[12]  Nicole A. Kirk,et al.  T-bet+ Memory B Cells Link to Local Cross-Reactive IgG upon Human Rhinovirus Infection , 2020, Cell reports.

[13]  Scott A. Jenks,et al.  Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations , 2019, Front. Immunol..

[14]  A. Trkola,et al.  Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells , 2019, The Journal of experimental medicine.

[15]  C. Wejse,et al.  T-cell and B-cell perturbations identify distinct differences in HIV-2 compared with HIV-1-induced immunodeficiency , 2019, AIDS.

[16]  Christopher D. Scharer,et al.  IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation , 2019, bioRxiv.

[17]  Yvan Saeys,et al.  A comparison of single-cell trajectory inference methods , 2019, Nature Biotechnology.

[18]  M. Cancro,et al.  T‐bet+ memory B cells: Generation, function, and fate , 2019, Immunological reviews.

[19]  F. Månsson,et al.  Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein–Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2–Infected Individuals , 2019, The Journal of infectious diseases.

[20]  Russell B. Fletcher,et al.  Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics , 2017, BMC Genomics.

[21]  H. Veiga-Fernandes,et al.  HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication , 2017, Mucosal Immunology.

[22]  F. Månsson,et al.  Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study. , 2018, The lancet. HIV.

[23]  N. Taveira,et al.  Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells , 2017, AIDS.

[24]  M. Betts,et al.  T-bet-expressing B cells during HIV and HCV infections. , 2017, Cellular immunology.

[25]  M. Ostrowski,et al.  T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response. , 2017, JCI insight.

[26]  O. Lund,et al.  CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection , 2016, AIDS.

[27]  A. Karlsson,et al.  Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections , 2016, AIDS.

[28]  Piet Demeester,et al.  FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[29]  F. Månsson,et al.  Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals , 2013, AIDS.

[30]  O. Lund,et al.  Multiparametric Bioinformatics Distinguish the CD4/CD8 Ratio as a Suitable Laboratory Predictor of Combined T Cell Pathogenesis in HIV Infection , 2014, The Journal of Immunology.

[31]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[32]  S. Rowland-Jones,et al.  Comparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis , 2013, Reviews in medical virology.

[33]  S. Rowland-Jones,et al.  Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection. , 2013, Blood.

[34]  F. Månsson,et al.  Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection. , 2013, AIDS research and human retroviruses.

[35]  J. Connolly,et al.  Optimal cellular preservation for high dimensional flow cytometric analysis of multicentre trials. , 2012, Journal of immunological methods.

[36]  F. Månsson,et al.  Effect of Complement on HIV-2 Plasma Antiviral Activity Is Intratype Specific and Potent , 2012, Journal of Virology.

[37]  N. Taveira,et al.  Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia , 2012, AIDS.

[38]  F. Månsson,et al.  Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. , 2012, The New England journal of medicine.

[39]  S. Rowland-Jones,et al.  Potent Autologous and Heterologous Neutralizing Antibody Responses Occur in HIV-2 Infection across a Broad Range of Infection Outcomes , 2011, Journal of Virology.

[40]  G. Gottlieb,et al.  Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection , 2011, Journal of Virology.

[41]  F. Antunes,et al.  Cell-Associated Viral Burden Provides Evidence of Ongoing Viral Replication in Aviremic HIV-2-Infected Patients , 2010, Journal of Virology.

[42]  S. Rowland-Jones,et al.  Highly avid, oligoclonal, early‐differentiated antigen‐specific CD8+ T cells in chronic HIV‐2 infection , 2010, European journal of immunology.

[43]  H. Whittle,et al.  Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village , 2010, Retrovirology.

[44]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[45]  F. Månsson,et al.  Prevalence and incidence of HIV-1 and HIV-2 before, during and after a civil war in an occupational cohort in Guinea-Bissau, West Africa , 2009, AIDS.

[46]  Wei Wang,et al.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals , 2008, The Journal of experimental medicine.

[47]  Mario Roederer,et al.  Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection , 2008 .

[48]  F. Brun-Vézinet,et al.  Differences in proviral DNA load between HIV-1- and HIV-2-infected patients , 2008, AIDS.

[49]  A. MacNeil,et al.  Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 Infection , 2007, Journal of Virology.

[50]  H. Whittle,et al.  Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic , 2007, AIDS.

[51]  S. Rowland-Jones,et al.  Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection1 , 2006, The Journal of Immunology.

[52]  L. Glimcher,et al.  T-bet-dependent expression of osteopontin contributes to T cell polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Biberfeld,et al.  Clinical Progression in Early and Late Stages of Disease in a Cohort of Individuals Infected with Human Immunodeficiency Virus-2 in Guinea-Bissau , 2003, Scandinavian journal of infectious diseases.

[54]  H. Whittle,et al.  Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. , 2002, AIDS research and human retroviruses.

[55]  J. Albert,et al.  Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. , 2000, Archives of internal medicine.

[56]  S. Popper,et al.  Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. , 1999, The Journal of infectious diseases.

[57]  H. Whittle,et al.  Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. , 1998, Journal of human virology.

[58]  S. Cousens,et al.  CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[59]  F. Dias,et al.  HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[60]  I. Thior,et al.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.

[61]  I. Thior,et al.  Slower heterosexual spread of HIV-2 than HIV-1 , 1994, The Lancet.

[62]  Paul G. Thomas,et al.  Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination , 2022 .